Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Integra picks up spinal assets

This article was originally published in The Gray Sheet

Executive Summary

Spinal unit of Integra LifeSciences acquires the assets of Innovative Spinal Technologies Inc. for $9.3 million through the latter firm's Chapter 7 bankruptcy auction process Sept. 14. The court-approved purchase includes the Paramount minimally invasive surgery/open system for percutaneous lumbar fusion, Paramount interbody fusion system, Cordant anterior cervical plating system, and over 100 patents

You may also be interested in...



Integra's Orthopedic Sales Up 9% On Double-Digit Extremity Growth

Integra LifeSciences' orthopedic device sales rose 9% to $70.2 million in the first quarter, driven by double-digit growth in extremity reconstructive devices, the company reported May 3

Financing Quarterly Statistics, Q1 2024

During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.

Helping Organizations Deliver On KPIs And Giving Staff A Voice

ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027961

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel